You are browsing the Hong Kong website, Regulated by Hong Kong SFC (CE number: BJA907). Investment is risky and you must be cautious when entering the market.
特一藥業(002728.SZ)業績快報:2020年度淨利潤降74.48%至4381.65萬元
格隆匯 04-06 17:57

格隆匯 4 月 6日丨特一藥業(002728.SZ)發佈2020年度業績快報,實現營業總收入6.33億元,同比下降31.31%;利潤總額5327.81萬元,同比下降72.94%;歸屬於上市公司股東的淨利潤4381.65萬元,同比下降74.48%;基本每股收益0.22元。

2020年初新冠肺炎疫情爆發以來,國家及各地政府相繼出台關於延遲復工、限制物流、人流等疫情防控措施,公司OTC產品的銷售活動開展受到極大的限制;受新冠疫情影響,各地監管部門紛紛限制和禁止感冒止咳類、發熱類用藥在醫院外銷售,在以上因素的綜合影響下,公司主要產品止咳感冒類藥物的需求減弱,營業收入顯著下降,特別是OTC產品的營業收入降幅很大,導致本報吿期公司營業收入與上年同期相比下降31.31%。在固定成本支出相對剛性的情況下,生產規模效益降低,導致公司淨利潤降幅較大在疫情的影響下,全資子公司海南海力製藥有限公包含商譽的資產組未來可回收金額出現減值跡象,經初步測算公司擬對其商譽計提減值準備2,242.42萬元,在以上因素的綜合影響下,報吿期公司淨利潤與上年同期相比下降74.48%

目前國內新冠疫情控制情況良好,新冠肺炎疫情防控已趨於常態化,影響公司產品終端銷售的各種限制措施有所放鬆,公司產品終端銷售情況正逐漸好轉,預計隨着疫情影響的進一步減弱,公司產品的銷量將逐步恢復。

Follow us
Find us on Facebook, Twitter , Instagram, and YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!
Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.
uSMART
Wealth Growth Made Easy
Open Account